US Patent Issued to Regeneron Pharmaceuticals on Feb. 24 for "Stabilized formulations containing anti-ANGPTL3 antibodies" (New York Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,551, issued on Feb. 24, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Stabilized formulations containing anti-ANGPTL3 antibodies" was invented by Dingjiang Liu (Pleasantville, N.Y.) and Andria Skinner (Mohegan Lake, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides stable pharmaceutical formulations comprising a human antibody that specifically binds to human angiopoietin-like protein 3 (ANGPTL3). The formulations may contain, in addition to an anti-ANGPTL3 antibody, a buffer; an organic cosolvent; at least one viscosity modifier, and optionally at least one amino acid. The pharmaceutical formula...